ClinicalTrials.gov
public full text
Public Domain
XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults
XW004 is an acylated human glucagon-like peptide 1 (GLP-1) analogue and is being developed for type 2 diabetes mellitus (T2DM) and obesity management.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients#906848
- Predicting Steroid Response Using Exhaled Nitric Oxide#812917
- Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')#1094336
- Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases#859037
- First-in-human Evaluation of [18F]CETO#877504
Record · ID 870899
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive